Cited by 705Muscle Physiology and DisordersMuscle metabolism and nutritionNutrition and Health in Aging

The DOI matches its Crossref record; 155 of the 157 references it cites were found in a registry or an index.

Glucocorticoid-induced skeletal muscle atrophy

Schakman, O., Kalista, S., Barbé, C., Loumaye, A., Thissen, J.P.·2013·The International Journal of Biochemistry & Cell Biology

DOI 10.1016/j.biocel.2013.05.036

Open this paper in CoChat — free account

Abstract

Many pathological states characterized by muscle atrophy (e.g., sepsis, cachexia, starvation, metabolic acidosis and severe insulinopenia) are associated with an increase in circulating glucocorticoids (GC) levels, suggesting that GC could trigger the muscle atrophy observed in these conditions. GC-induced muscle atrophy is characterized by fast-twitch, glycolytic muscles atrophy illustrated by decreased fiber cross-sectional area and reduced myofibrillar protein content. GC-induced muscle atrophy results from increased protein breakdown and decreased protein synthesis. Increased muscle proteolysis, in particular through the activation of the ubiquitin proteasome and the lysosomal systems, is considered to play a major role in the catabolic action of GC. The stimulation by GC of these two proteolytic systems is mediated through the increased expression of several Atrogenes ("genes involved in atrophy"), such as FOXO, Atrogin-1, and MuRF-1. The inhibitory effect of GC on muscle protein synthesis is thought to result mainly from the inhibition of the mTOR/S6 kinase 1 pathway. These changes in muscle protein turnover could be explained by changes in the muscle production of two growth factors, namely Insulin-like Growth Factor (IGF)-I, a muscle anabolic growth factor and Myostatin, a muscle catabolic growth factor. This review will discuss the recent progress made in the understanding of the mechanisms involved in GC-induced muscle atrophy and consider the implications of these advancements in the development of new therapeutic approaches for treating GC-induced myopathy. This article is part of a Directed Issue entitled: Molecular basis of muscle wasting.

Integrity signals

Registry

Crossref · 10.1016/j.biocel.2013.05.036

Cites

155 of 155 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

FOXO1 Regulates the Expression of 4E-BP1 and Inhibits mTOR Signaling in Mammalian Skeletal Muscle
Southgate, R. J., Neill, B., Prelovsek, O., El‐Osta, A., Kamei, Y., Miura, S., Ezaki, O., McLoughlin, T. J., Zhang, W., Unterman, T. G., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702039200 · Cited by 112
Retracted
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Double muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways
Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D., & Glass, D. J. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1009 · Cited by 1,583
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S. R., Mitch, W. E., & Goldberg, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0610com · Cited by 1,539 · cited 1×
“…analyses of muscle atrophy due to a variety of wasting diseases are several genes (Atrogin-1, MuRF-1, Cathepsin-L, PDK4, p21, Gadd45, 4E-BP1) controlled by the FOXO transcription factors (Almon et al., 2007; Jagoe et al., 2002; Komamura et al., 2003; Lecker et al., 2004; Waddell et al., 2008).”
Background
Mechanisms of Muscle Wasting — The Role of the Ubiquitin–Proteasome Pathway
Mitch, W. E., & Goldberg, A. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612193352507 · Cited by 1,163
Growth Hormone and the Insulin-Like Growth Factor System in Myogenesis*
Florini, J. R., Ewton, D. Z., & Coolican, S. A. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-5-481 · Cited by 1,148
Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation
Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., & Kambadur, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004356200 · Cited by 1,014

Flagged first, then by citations

Show all 157 references

2 of the 157 references couldn’t be matched to a known paper.

Sorted by citations

Complications of Cushing's syndrome: state of the art
Pivonello, R., Isidori, A. M., Martino, M. C. D., Newell-Price, J. D. C., Biller, B. M. K., & Colao, A. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00086-3 · Cited by 694
Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆
Arends, J., Strasser, F., Gonella, S., Solheim, T. S., Madeddu, C., Ravasco, P., Buonaccorso, L., de van der Schueren, M. A. E., Baldwin, C., Chasen, M., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100092 · Cited by 586
Understanding cachexia as a cancer metabolism syndrome
Porporato, P. E. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.3 · Cited by 562
Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications
Ostrovidov, S., Hosseini, V., Ahadian, S., Fujie, T., Parthiban, S. P., Ramalingam, M., Bae, H., Kaji, H., & Khademhosseini, A. (2014) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2013.0534 · Cited by 302
Growth Hormone(s), Testosterone, Insulin-Like Growth Factors, and Cortisol: Roles and Integration for Cellular Development and Growth With Exercise
Kraemer, W. J., Ratamess, N. A., Hymer, W. C., Nindl, B. C., & Fragala, M. S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00033 · Cited by 339
Post-COVID-19 acute sarcopenia: physiopathology and management
Piotrowicz, K., Gąsowski, J., Michel, J., & Veronese, N. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-01942-8 · Cited by 257
The Determinants of Peak Bone Mass
Gordon, C. M., Zemel, B. S., Wren, T. A. L., Leonard, M. B., Bachrach, L. K., Rauch, F., Gilsanz, V., Rosen, C. J., & Winer, K. K. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.09.056 · Cited by 238
The effect of training volume and intensity on improvements in muscular strength and size in resistance-trained men
Mangine, G. T., Hoffman, J. R., Gonzalez, A. M., Townsend, J. R., Wells, A. J., Jajtner, A. R., Beyer, K. S., Boone, C. H., Miramonti, A. A., Wang, R., et al. (2015) · Physiological Reports · doi:10.14814/phy2.12472 · Cited by 204
Macrophages Are Key Regulators of Stem Cells during Skeletal Muscle Regeneration and Diseases
Dort, J., Fabre, P., Molina, T., & Dumont, N. A. (2019) · Stem Cells International · doi:10.1155/2019/4761427 · Cited by 211
Skeletal muscle wasting with disuse atrophy is multi-dimensional: the response and interaction of myonuclei, satellite cells and signaling pathways
Brooks, N. E., & Myburgh, K. H. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00099 · Cited by 206
Molecular networks in skeletal muscle plasticity
Hoppeler, H. H. (2016) · Journal of Experimental Biology · doi:10.1242/jeb.128207 · Cited by 213
Metabolic comorbidities in Cushing's syndrome
Ferraù, F., & Korbonits, M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0354 · Cited by 226
Glucocorticoids and Skeletal Muscle
Bodine, S. C., & Furlow, J. D. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2895-8_7 · Cited by 180
The ubiquitin proteasome system in atrophying skeletal muscle: roles and regulation
Bilodeau, P., Coyne, E. S., & Wing, S. S. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00125.2016 · Cited by 188
Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia
Sartori, R., Hagg, A., Zampieri, S., Armani, A., Winbanks, C. E., Viana, L. R., Haidar, M., Watt, K. I., Qian, H., Pezzini, C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aay9592 · Cited by 159
Cancer-induced anorexia and malaise are mediated by CGRP neurons in the parabrachial nucleus
Campos, C., Bowen, A. J., Han, S., Wisse, B. E., Palmiter, R. D., & Schwartz, M. W. (2017) · Nature Neuroscience · doi:10.1038/nn.4574 · Cited by 150
Glucocorticoid Signaling: An Update from a Genomic Perspective
Sacta, M. A., Chinenov, Y. V., & Rogatsky, I. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105323 · Cited by 155
Antiaging diets: Separating fact from fiction
Lee, M. B., Hill, C. M., Bitto, A., & Kaeberlein, M. R. (2021) · Science · doi:10.1126/science.abe7365 · Cited by 147
A muscle-liver-fat signalling axis is essential for central control of adaptive adipose remodelling
Shimizu, N., Maruyama, T., Yoshikawa, N., Matsumiya, R., Ma, Y., Ito, N., Tasaka, Y., Souta-Kuribara, A., Miyata, K., Oike, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms7693 · Cited by 138
Glucocorticoids Induce Bone and Muscle Atrophy by Tissue-Specific Mechanisms Upstream of E3 Ubiquitin Ligases
Sato, A. Y., Richardson, D., Cregor, M. D., Davis, H. M., Au, E. D., McAndrews, K., Zimmers, T. A., Organ, J. M., Peacock, M., Plotkin, L. I., et al. (2017) · Endocrinology · doi:10.1210/en.2016-1779 · Cited by 144
Muscle wasting and aging: Experimental models, fatty infiltrations, and prevention
Brioche, T., Pagano, A. F., Py, G., & Chopard, A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.04.006 · Cited by 129
Skeletal Muscle Abnormalities in Heart Failure
Kinugawa, S., Takada, S., Matsushima, S., Okita, K., & Tsutsui, H. (2015) · International Heart Journal · doi:10.1536/ihj.15-108 · Cited by 140
Polyphenols and Their Effects on Muscle Atrophy and Muscle Health
Nikawa, T., Ulla, A., & Sakakibara, I. (2021) · Molecules · doi:10.3390/molecules26164887 · Cited by 146
Protection From Glucocorticoid-Induced Osteoporosis by Anti-Catabolic Signaling in the Absence of Sost/Sclerostin
Sato, A. Y., Cregor, M. D., Delgado‐Calle, J., Condon, K. W., Allen, M. R., Peacock, M., Plotkin, L. I., & Bellido, T. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2869 · Cited by 135
Frontiers in sarcopenia: Advancements in diagnostics, molecular mechanisms, and therapeutic strategies
Liu, D., Wang, S., Liu, S., Wang, Q., Che, X., & Wu, G. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101270 · Cited by 157
Mitochondrial Dysfunction Launches Dexamethasone-Induced Skeletal Muscle Atrophy via AMPK/FOXO3 Signaling
Liu, J., Peng, Y., Wang, X., Fan, Y., Qin, C., Shi, L., Tang, Y., Cao, K., Li, H., Long, J., et al. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00516 · Cited by 133
The Muscle Stem Cell Niche in Health and Disease
Mashinchian, O., Pisconti, A., Moal, E. L., & Bentzinger, C. F. (2017) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2017.08.003 · Cited by 140
Correlation between lumbar dysfunction and fat infiltration in lumbar multifidus muscles in patients with low back pain
Hildebrandt, M., Fankhauser, G., Meichtry, A., & Luomajoki, H. A. (2017) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-016-1376-1 · Cited by 130
Peripheral muscle abnormalities in cystic fibrosis: Etiology, clinical implications and response to therapeutic interventions
Gruet, M., Troosters, T., & Vergès, S. (2017) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.02.007 · Cited by 131
Role of branched‐chain amino acid–catabolizing enzymes in intertissue signaling, metabolic remodeling, and energy homeostasis
Biswas, D., Duffley, L., & Pulinilkunnil, T. (2019) · The FASEB Journal · doi:10.1096/fj.201802842rr · Cited by 126
Skeletal muscle atrophy and dysfunction in breast cancer patients: role for chemotherapy-derived oxidant stress
Guigni, B. A., Callahan, D. M., Tourville, T. W., Miller, M. S., Fiske, B. R., Voigt, T. B., Korwin-Mihavics, B. R., Anathy, V., Dittus, K. L., & Toth, M. J. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00002.2018 · Cited by 125
Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions
Siddiqui, J. A., Pothuraju, R., Jain, M., Batra, S. K., & Nasser, M. W. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188359 · Cited by 126
Cushing's syndrome: Overview of clinical presentation, diagnostic tools and complications
Barbot, M., Zilio, M., & Scaroni, C. M. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101380 · Cited by 126
Biological basis and treatment of frailty and sarcopenia
Sato, R., Vatic, M., da Fonseca, G. W. P., Anker, S. D., & von Haehling, S. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae073 · Cited by 130
Sarcopenia in Chronic Kidney Disease: Factors, Mechanisms, and Therapeutic Interventions
Watanabe, H., Enoki, Y., & Maruyama, T. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00513 · Cited by 130
Molecular Mechanisms of Obesity-Induced Osteoporosis and Muscle Atrophy
Roy, B., Curtis, M. E., Fears, L., Nahashon, S. N., & Fentress, H. M. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00439 · Cited by 122
Glucocorticoids in multiple myeloma: past, present, and future
Burwick, N. R., & Sharma, S. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3465-8 · Cited by 113
Connecting Myokines and Metabolism
Ahima, R. S., & Park, H. K. (2015) · Endocrinology and Metabolism · doi:10.3803/enm.2015.30.3.235 · Cited by 111
Trimetazidine attenuates dexamethasone-induced muscle atrophy via inhibiting NLRP3/GSDMD pathway-mediated pyroptosis
Wang, L., Jiao, X.-F., Wu, C., Li, X., Sun, H., Shen, X.-Y., Zhang, K., Zhao, C., Liu, L., Wang, M., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00648-0 · Cited by 114
Steroid-induced hyperglycemia: An underdiagnosed problem or clinical inertia? A narrative review
Bonaventura, A., & Montecucco, F. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.006 · Cited by 108
Dexamethasone-induced autophagy mediates muscle atrophy through mitochondrial clearance
Troncoso, R., Paredes, F., Parra, V., Gatica, D., Vásquez-Trincado, C., Quiroga, C., Bravo, R., López‐Crisosto, C., Rodriguez, A. E., Oyarzún, A. P., et al. (2014) · Cell Cycle · doi:10.4161/cc.29272 · Cited by 113
Rehabilitation in Patients before and after Lung Transplantation
Langer, D. (2015) · Respiration · doi:10.1159/000430451 · Cited by 106
Fear of Movement and Low Self-Efficacy Are Important Barriers in Physical Activity after Renal Transplantation
Zelle, D. M., Corpeleijn, E., Klaassen, G., Schutte, E., Navis, G. J., & Bakker, S. J. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147609 · Cited by 105
Anabolic Resistance in the Pathogenesis of Sarcopenia in the Elderly: Role of Nutrition and Exercise in Young and Old People
Tezze, C., Sandri, M., & Tessari, P. (2023) · Nutrients · doi:10.3390/nu15184073 · Cited by 114
Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy
Mah, J. K., Clemens, P. R., Guglieri, M., Smith, E. C., Finkel, R. S., Tulinius, M., Nevo, Y., Ryan, M. M., Webster, R., Castro, D., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.44178 · Cited by 99
Blocking extracellular activation of myostatin as a strategy for treating muscle wasting
Pirruccello, M., Jackson, J., Wawersik, S., Webster, M. T., Salta, L., Long, K. K., McConaughy, W., Capili, A. D., Boston, C., Carven, G. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-20524-9 · Cited by 101
Role of hormones in sarcopenia
Priego, T., Martı́n, A. I., González‐Hedström, D., Granado, M., & López‐Calderón, A. (2021) · Vitamins and hormones · doi:10.1016/bs.vh.2020.12.021 · Cited by 103
Glucocorticoids, Inflammation and Bone
Güler-Yüksel, M., Hoes, J. N., Bultink, I. E. M., & Lems, W. F. (2018) · Calcified Tissue International · doi:10.1007/s00223-017-0335-7 · Cited by 92
Antioxidant Apigenin Relieves Age-Related Muscle Atrophy by Inhibiting Oxidative Stress and Hyperactive Mitophagy and Apoptosis in Skeletal Muscle of Mice
Wang, D., Yang, Y., Zou, X., Zhang, J., Zheng, Z., & Wang, Z. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa214 · Cited by 87
The Role of ACTH and Corticosteroids for Sepsis and Septic Shock: An Update
Annane, D. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00070 · Cited by 84
Meeting Report: Consensus Recommendations for a Research Agenda in Exercise in Solid Organ Transplantation
Mathur, S., Janaudis‐Ferreira, T., Wickerson, L. M., Singer, L. G., Patcai, J., Rozenberg, D., Blydt‐Hansen, T. D., Hartmann, E. L., Haykowsky, M. J., Helm, D., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12874 · Cited by 83
Effect of Quercetin on Dexamethasone-Induced C2C12 Skeletal Muscle Cell Injury
Chen, C., Yang, J., Lu, C., Chiu, Y., Chen, H., Chung, M., Wu, Y., & Chen, F. (2020) · Molecules · doi:10.3390/molecules25143267 · Cited by 84
Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy
Dort, J., Orfi, Z., Fabre, P., Molina, T., Conte, T. C., Greffard, K., Pellerito, O., Bilodeau, J., & Dumont, N. A. (2021) · Nature Communications · doi:10.1038/s41467-021-26516-0 · Cited by 81
Home parenteral nutrition increases fat free mass in patients with incurable gastrointestinal cancer. Results of a randomized controlled trial
Obling, S. R., Wilson, B., Pfeiffer, P., & Kjeldsen, J. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.12.011 · Cited by 78
The Role of Wnt Signaling and Sclerostin in the Pathogenesis of Glucocorticoid-Induced Osteoporosis
Guañabens, N., Gifre, L., & Peris, P. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0197-0 · Cited by 76
Assessment of season-dependent body condition scores in relation to faecal glucocorticoid metabolites in free-ranging Asian elephants
Pokharel, S. S., Seshagiri, P. B., & Sukumar, R. (2017) · Conservation Physiology · doi:10.1093/conphys/cox039 · Cited by 75
Hormones and Muscle Atrophy
Martı́n, A. I., Priego, T., & López‐Calderón, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_9 · Cited by 84
Stress and body condition are associated with climate and demography in Asian elephants
Mumby, H. S., Mar, K. U., Thitaram, C., Courtiol, A., Towiboon, P., Min-Oo, Z., Htut-Aung, Y., Brown, J. L., & Lummaa, V. (2015) · Conservation Physiology · doi:10.1093/conphys/cov030 · Cited by 72
Rictor/mTORC2 facilitates central regulation of energy and glucose homeostasis
Kocalis, H. E., Hagan, S. L., George, L., Turney, M. K., Siuta, M., Laryea, G. N., Morris, L. C., Muglia, L. J., Printz, R. L., Stanwood, G. D., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.01.014 · Cited by 76
Effects of plant-derived isoquinoline alkaloids on growth performance and intestinal function of broiler chickens under heat stress
Kikusato, M., Xue, G.-D., Pastor, A., Niewold, T., & Toyomizu, M. (2020) · Poultry Science · doi:10.1016/j.psj.2020.11.050 · Cited by 70
β-Hydroxy-β-Methylbutyrate (HMB) Normalizes Dexamethasone-Induced Autophagy-Lysosomal Pathway in Skeletal Muscle
Girón, M. D., Vílchez, J. D., Shreeram, S., Salto, R., Manzano, M., Cabrera, E., Campos, N., Edens, N. K., Rueda, R., & López-Pedrosa, J. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117520 · Cited by 71
Increased Serpina3n release into circulation during glucocorticoid‐mediated muscle atrophy
Gueugneau, M., d’Hose, D., Barbé, C., de Barsy, M., Lause, P., Maiter, D. M., Bindels, L. B., Delzenne, N. M., Schaeffer, L., Gangloff, Y., et al. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12315 · Cited by 72
Mechanisms Involved in Gut Microbiota Regulation of Skeletal Muscle
Li, G., Jin, B., & Fan, Z. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2151191 · Cited by 72
Increased Adenine Nucleotide Degradation in Skeletal Muscle Atrophy
Miller, S. G., Hafen, P. S., & Brault, J. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010088 · Cited by 67
Muscle in Endocrinology: From Skeletal Muscle Hormone Regulation to Myokine Secretion and Its Implications in Endocrine–Metabolic Diseases
Iglesias, P. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14134490 · Cited by 79
Integrated genomic and proteomic analyses identify stimulus-dependent molecular changes associated with distinct modes of skeletal muscle atrophy
Hunt, L. C., Graça, F. A., Pagala, V., Wang, Y., Li, Y., Yuan, Z., Fan, Y., Labelle, M., Peng, J., & Demontis, F. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109971 · Cited by 74
Impact of hypercortisolism on skeletal muscle mass and adipose tissue mass in patients with adrenal adenomas
Delivanis, D. A., Iñiguez‐Ariza, N. M., Zeb, M. H., Moynagh, M. R., Takahashi, N., McKenzie, T. J., Thomas, M. A., Gogos, C. A., Young, W. F., Bancos, I., et al. (2017) · Clinical Endocrinology · doi:10.1111/cen.13512 · Cited by 67
Cortisol excess in chronic kidney disease – A review of changes and impact on mortality
Sagmeister, M. S., Harper, L., & Hardy, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1075809 · Cited by 74
Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis
Raterman, H. G., Bultink, I. E. M., & Lems, W. F. (2019) · Drugs · doi:10.1007/s40265-019-01145-6 · Cited by 64
Dihydromyricetin Attenuates Dexamethasone-Induced Muscle Atrophy by Improving Mitochondrial Function Via the PGC-1α Pathway
Huang, Y., Chen, K., Ren, Q., Yi, L., Zhu, J., Zhang, Q., & Mi, M. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000493040 · Cited by 64
The Prediction and Monitoring of Toxicity Associated with Long-Term Systemic Glucocorticoid Therapy
Harris, E., Tiganescu, A., Tubeuf, S., & Mackie, S. L. (2015) · Current Rheumatology Reports · doi:10.1007/s11926-015-0513-4 · Cited by 63
Rev-erb-α regulates atrophy-related genes to control skeletal muscle mass
Mayeuf-Louchart, A., Thorel, Q., Delhaye, S., Beauchamp, J., Duhem, C., Danckaert, A., Lancel, S., Pourcet, B., Woldt, E., Boulinguiez, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14596-2 · Cited by 66
Glucocorticoids Enhance Muscle Proteolysis through a Myostatin-Dependent Pathway at the Early Stage
Wang, R., Jiao, H., Zhao, J., Wang, X., & Lin, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156225 · Cited by 68
Nutraceuticals in the Prevention and Treatment of the Muscle Atrophy
Wang, Y., Liu, Q., Quan, H., Kang, S.-G., Huang, K., & Tong, T. (2021) · Nutrients · doi:10.3390/nu13061914 · Cited by 61
11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension
Hardy, R., Botfield, H. F., Markey, K. A., Mitchell, J., Alimajstorovic, Z., Westgate, C. S. J., Sagmeister, M. S., Fairclough, R. J., Ottridge, R. S., Yiangou, A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa766 · Cited by 58
Fine-tuning of NFκB by glycogen synthase kinase 3β directs the fate of glomerular podocytes upon injury
Bao, H. F., Ge, Y., Peng, A., & Gong, R. (2015) · Kidney International · doi:10.1038/ki.2014.428 · Cited by 62
miR‐29c improves skeletal muscle mass and function throughout myocyte proliferation and differentiation and by repressing atrophy‐related genes
Silva, W. J., Graça, F. A., Cruz, A., Silvestre, J. G., Labeit, S., Miyabara, E. H., Yan, C. Y. I., Wang, D. Z., & Moriscot, A. S. (2019) · Acta Physiologica · doi:10.1111/apha.13278 · Cited by 60
The Renin-Angiotensin System and Skeletal Muscle
Powers, S. K., Morton, A. B., Hyatt, H. W., & Hinkley, J. M. (2018) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000158 · Cited by 62
Modulating glucocorticoid receptor actions in physiology and pathology: Insights from coregulators
Fadel, L., Dacic, M., Fonda, V., Sokolsky, B. A., Quagliarini, F., Rogatsky, I., & Uhlenhaut, N. H. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108531 · Cited by 63
Screening with a Novel Cell-Based Assay for TAZ Activators Identifies a Compound That Enhances Myogenesis in C2C12 Cells and Facilitates Muscle Repair in a Muscle Injury Model
Yang, Z., Nakagawa, K., Sarkar, A., Maruyama, J., Iwasa, H., Bao, Y., Ishigami‐Yuasa, M., Ito, S., Kagechika, H., Hata, S., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01346-13 · Cited by 58
The efficacy of exercise training in kidney transplant recipients: a meta-analysis and systematic review
Oguchi, H., Tsujita, M., Yazawa, M., Kawaguchi, T., Hoshino, J., Kohzuki, M., Ito, O., Yamagata, K., Shibagaki, Y., & Sofue, T. (2018) · Clinical and Experimental Nephrology · doi:10.1007/s10157-018-1633-8 · Cited by 57
Exercise, skeletal muscle and inflammation: ARE-binding proteins as key regulators in inflammatory and adaptive networks
Beiter, T., Hoene, M., Prenzler, F., Mooren, F. C., Steinacker, J. M., Weigert, C., Niess, A. M., & Munz, B. (2026) · PubMed · doi:10.22029/eir.2015.1695 · Cited by 56
Dexamethasone-induced muscular atrophy is mediated by functional expression of connexin-based hemichannels
Cea, L. A., Balboa, E., Puebla, C., Vargas, A. A., Cisterna, B. A., Escamilla, R., Regueira, T., & Sáez, J. C. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.07.003 · Cited by 54
Short-term glucocorticoid-related side effects and adverse reactions: a narrative review and practical approach
Noetzlin, S., Bréville, G., Seebach, J. D., & Gastaldi, G. (2022) · Swiss Medical Weekly · doi:10.4414/smw.2022.w30088 · Cited by 64
Pediatric Lung Transplantation
Sweet, S. C. (2017) · Respiratory Care · doi:10.4187/respcare.05304 · Cited by 54
Skeletal Muscle Response to Deflazacort, Dexamethasone and Methylprednisolone
Fappi, A., Neves, J. D. C., Sanches, L. N., Silva, P. V. M. E., Sikusawa, G. Y., Brandão, T. C. P., Chadi, G., & Zanoteli, E. (2019) · Cells · doi:10.3390/cells8050406 · Cited by 54
Handgrip Strength and Pulmonary Disease in the Elderly: What is the Link?
Lima, T. R. L., de Almeida, V. P., Ferreira, A. D. S., Guimarães, F. S., & Lopes, A. J. (2019) · Aging and Disease · doi:10.14336/ad.2018.1226 · Cited by 59
Serum adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing spondylitis. A comparative study
Toussirot, É. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00453 · Cited by 53
Mechanisms of protein balance in skeletal muscle
Anthony, T. G. (2016) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2016.02.012 · Cited by 59
Continuous corticosterone delivery via the drinking water or pellet implantation: A comparative study in mice
Gasparini, S. J., Weber, M.-C., Henneicke, H., Kim, S., Zhou, H., & Seibel, M. J. (2016) · Steroids · doi:10.1016/j.steroids.2016.10.008 · Cited by 52
Three-Dimensional Culture Model of Skeletal Muscle Tissue with Atrophy Induced by Dexamethasone
Shimizu, K., Genma, R., Yuuki, G., Nagasaka, S., & Honda, H. (2017) · Bioengineering · doi:10.3390/bioengineering4020056 · Cited by 54
Morin attenuates dexamethasone-mediated oxidative stress and atrophy in mouse C2C12 skeletal myotubes
Ulla, A., Uchida, T., Miki, Y., Sugiura, K., Higashitani, A., Kobayashi, T., Ohno, A., Nakao, R., Hirasaka, K., Sakakibara, I., et al. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.108873 · Cited by 56
Nutrients against Glucocorticoid-Induced Muscle Atrophy
Lee, M., Jeong, H. H., Kim, M., Ryu, H., Baek, J.-W., & Lee, B. (2022) · Foods · doi:10.3390/foods11050687 · Cited by 55
Monotropein Improves Dexamethasone-Induced Muscle Atrophy via the AKT/mTOR/FOXO3a Signaling Pathways
Wang, P., Kang, S. Y., Kim, S. J., Park, Y., & Jung, H. W. (2022) · Nutrients · doi:10.3390/nu14091859 · Cited by 49
Glucocorticoid Excess in Bone and Muscle
Sato, A. Y., Peacock, M., & Bellido, T. (2018) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-018-9242-3 · Cited by 50
Sex Difference in Corticosterone-Induced Insulin Resistance in Mice
Kaikaew, K., Steenbergen, J., van Dijk, T. H., Grefhorst, A., & Visser, J. A. (2019) · Endocrinology · doi:10.1210/en.2019-00194 · Cited by 51
Natural and synthetic compounds as dissociated agonists of glucocorticoid receptor
Zhang, T., Liang, Y., & Zhang, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104802 · Cited by 49
FGF-2 targets sclerostin in bone and myostatin in skeletal muscle to mitigate the deleterious effects of glucocorticoid on musculoskeletal degradation
Adhikary, S., Choudhary, D., Tripathi, A. K., Karvande, A., Ahmad, N., Kothari, P., & Trivedi, R. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.05.022 · Cited by 47
Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs
Rodgers, B. D., & Ward, C. W. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab030 · Cited by 111
Acute Sarcopenia: Mechanisms and Management
Damanti, S., Senini, E., LORENZO, R. D., Merolla, A., Santoro, S., Festorazzi, C., Messina, M., Vitali, G., Sciorati, C., & Rovere, P. Q. (2024) · Nutrients · doi:10.3390/nu16203428 · Cited by 53

Authors: Schakman, O., Kalista, S., Barbé, C., Loumaye, A., & Thissen, J. P.
Affiliations: UCLouvain (BE)
Corresponding author: Thissen, J.P.
ORCID: Schakman, O.
Barbé, C.
Loumaye, A.
Venue: The International Journal of Biochemistry & Cell Biology
Publisher: Elsevier BV
Published: 2013-10
Volume: 45
Issue: 10
Pages: 2163-2172
ISSN: 1357-2725 (ISSN-L)
DOI: 10.1016/j.biocel.2013.05.036
OpenAlex: W2092885411
Cited by: 705
References: 157
Citations by year: 2026: 81 · 2025: 74 · 2024: 58 · 2023: 60 · 2022: 68 · 2021: 62 · 2020: 58 · 2019: 43 · 2018: 44 · 2017: 37 · 2016: 45 · 2015: 48 · 2014: 24 · 2013: 2
FWCI: 3.73
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The International Journal of Biochemistry & Cell Biology (publishedVersion)
PubMed (publishedVersion)
Digital Access to Libraries (submittedVersion)
Funders: Fund for Scientific Medical Research (Belgium)
National Fund for Scientific Research (Belgium)
Association Française contre les Myopathies (France)
Association Belge contre les Maladies neuro-musculaires
Fonds Spéciaux de Recherche (Université catholique de Louvain, Belgium)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
Keywords: glucocorticoid-induced muscle atrophy, skeletal muscle atrophy, muscle protein degradation, ubiquitin-proteasome system, lysosomal proteolysis, atrogenes, atrogin-1, MuRF1, FOXO, muscle protein synthesis, insulin-like growth factor I, myostatin, glucocorticoid-induced myopathy, cachexia, sepsis
MeSH terms: Animals, Glucocorticoids, Humans, Muscular Atrophy, Protein Biosynthesis, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Glucocorticoid-induced skeletal muscle atrophy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks